RFG
NVO

Range Financial Group’s Novo Nordisk NVO Stock Holding History

Range Financial Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.61M Buy
54,505
+46,119
+550% +$1.98M 0.71% 46
2026
Q1 		$308K Sell
8,386
-856
-9% -$40.6K 0.1% 167
2025
Q4 		$470K Sell
9,242
-28,269
-75% -$1.45M 0.16% 139
2025
Q3 		$2.08M Buy
37,511
+26,020
+226% +$1.52M 0.75% 35
2025
Q2 		$793K Buy
11,491
+350
+3% +$23.8K 0.31% 98
2025
Q1 		$774K Buy
11,141
+1,177
+12% +$97.2K 0.34% 93
2024
Q4 		$857K Buy
+9,964
New +$1.08M 0.4% 78
2024
Q3 		– Sell
-9,731
Closed -$1.39M – 143
2024
Q2 		$1.39M Sell
9,731
-96
-1% -$12.7K 0.71% 45
2024
Q1 		$1.26M Sell
9,827
-6
-0.1% -$714 0.66% 52
2023
Q4 		$1.02M Sell
9,833
-581
-6% -$57.5K 0.61% 58
2023
Q3 		$947K Sell
10,414
-712
-6% -$62.7K 0.63% 61
2023
Q2 		$900K Sell
11,126
-1,402
-11% -$115K 0.57% 67
2023
Q1 		$997K Sell
12,528
-1,816
-13% -$129K 0.65% 59
2022
Q4 		$971K Buy
14,344
+342
+2% +$20.1K 0.66% 54
2022
Q3 		$698K Sell
14,002
-258
-2% -$13.8K 0.54% 79
2022
Q2 		$794K Sell
14,260
-752
-5% -$41.7K 0.58% 71
2022
Q1 		$834K Sell
15,012
-32,658
-69% -$1.68M 0.53% 75
2021
Q4 		$2.67M Sell
47,670
-2,220
-4% -$120K 1.76% 6
2021
Q3 		$2.4M Sell
49,890
-5,194
-9% -$251K 1.72% 7
2021
Q2 		$2.31M Buy
55,084
+7,298
+15% +$283K 1.7% 7
2021
Q1 		$1.61M Buy
+47,786
New +$1.7M 1.47% 11

Other funds holding NVO

EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return

Range Financial Group's NVO Position: Q2 2026 in Review

Range Financial Group increased its Novo Nordisk (NVO) stake by 550% in Q2 2026, buying an estimated $1.98M and bringing the position to 54,505 shares worth $2.61M. The position accounts for 0.71% of the portfolio, ranked #46.

Range Financial Group first reported a position in NVO in Q1 2021 and has held it in 21 quarters since. The position peaked at $2.67M in Q4 2021. 623 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Range Financial Group held 54,505 shares of Novo Nordisk worth $2.61M as of Q2 2026.
  • Range Financial Group bought 46,119 Novo Nordisk shares in Q2 2026, an estimated $1.98M.
  • Novo Nordisk made up 0.71% of Range Financial Group's portfolio in Q2 2026, its #46 holding.
  • Range Financial Group first reported a position in Novo Nordisk in Q1 2021 and has held it in 21 quarters since.
  • Range Financial Group's Novo Nordisk position peaked at $2.67M in Q4 2021.
  • 623 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Range Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.